Special Report By Lev Facher First-of-its-kind examination shows how widely pharma showers campaign cash at the state level
Business By Rebecca Robbins A startup promised to make health care ‘refreshingly simple.’ Building the business has been anything but
Health By Andrew Joseph ‘A blizzard of prescriptions’: Documents reveal new details about Purdue’s marketing of OxyContin
Pharmalot By Ed Silverman Out-of-pocket spending on specialty drugs dropped dramatically after states capped costs
Health By Elizabeth Cooney Who gets hospitalized for Covid-19? Report shows differences by race and sex
Health By Rebecca Robbins and Talia Bronshtein Explore: How many young doctors does your state retain after residency?
First Opinion By Scott Brunner FDA’s overreach will harm compounding pharmacies and the patients they serve
Health By JoNel Aleccia — Kaiser Health News Where you live may determine how you die, study suggests
Politics By Andrew Joseph, Lev Facher, Kate Sheridan, and Nicholas Florko Shalala loses — and other 2020 election results that will have big implications for health and science
First Opinion By Kacie Kidd and Gina Sequeira Laws to ban gender-affirming care could increase youth suicides, parents fear
Politics By Usha Lee McFarling With wildfires burning and Covid-19 spreading, can California afford stem cell research? Voters are set to decide
Health By Andrew Joseph ‘At a breaking point’: New surge of Covid-19 cases has states, hospitals scrambling, yet again
Politics By Nicholas Florko Drug makers sue to block Minnesota law making it cheaper to get insulin in emergencies
Pharmalot By Ed Silverman Maryland governor vetoes funding for a prescription drug affordability board
Politics By Nicholas Florko After a hard-won political fight, this state expanded access to insulin. Can others follow its lead?
Politics By Lev Facher Trump outlines ‘phases’ for reopening states once coronavirus cases begin to decline
Politics By Nicholas Florko State legislatures are lapping the federal government on drug pricing — even amid the coronavirus
Politics By Lev Facher ‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law
Pharmalot By Ed Silverman Americans with employer coverage saw growth in drug spending outpace other medical costs
Pharmalot By Ed Silverman Bristol-Myers and Sanofi accuse Hawaii of violating their free speech rights
Health By Andrew Joseph and Shraddha Chakradhar Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show
Pharmalot By Ed Silverman Florida becomes the latest state to examine Sun Pharma licenses for distributing samples
Pharmalot By Ed Silverman Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals
Biotech By Scott Kirsner — Boston Globe In tight Massachusetts job market, it’s relo for biotech and remote for tech hires
Health By Helen Branswell Why the huge surge in EEE cases? Federal rules requiring quick sample disposal mean we may never know
Pharmalot By Ed Silverman Generic trade group sues California for an ‘unconstitutional’ law banning pay-to-delay deals
Politics By Priyanka Dayal McCluskey — Boston Globe and Matt Stout — Boston Globe Mass. governor — and one-time insurance executive — eyes a legacy-defining revamp of state’s health care
Pharmalot By Ed Silverman Most state Medicaid programs continue to restrict access to hepatitis C medicines
Business By Andrew Joseph Purdue Pharma filed for bankruptcy. What does it mean for lawsuits against the opioid manufacturer?